These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24853427)

  • 1. The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption.
    Lee MW; Bassiouni R; Sparrow NA; Iketani A; Boohaker RJ; Moskowitz C; Vishnubhotla P; Khaled AS; Oyer J; Copik A; Fernandez-Valle C; Perez JM; Khaled AR
    Cell Death Dis; 2014 May; 5(5):e1249. PubMed ID: 24853427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational development of a cytotoxic peptide to trigger cell death.
    Boohaker RJ; Zhang G; Lee MW; Nemec KN; Santra S; Perez JM; Khaled AR
    Mol Pharm; 2012 Jul; 9(7):2080-93. PubMed ID: 22591113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chaperonin Containing TCP-1 Protein Level in Breast Cancer Cells Predicts Therapeutic Application of a Cytotoxic Peptide.
    Bassiouni R; Nemec KN; Iketani A; Flores O; Showalter A; Khaled AS; Vishnubhotla P; Sprung RW; Kaittanis C; Perez JM; Khaled AR
    Clin Cancer Res; 2016 Sep; 22(17):4366-79. PubMed ID: 27012814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidation of Therapeutic Peptide Binding Partners from Isolated Mitochondria.
    Mozayan A; Khaled A
    Cureus; 2018 Jun; 10(6):e2898. PubMed ID: 30397556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEG-GO@XN nanocomposite suppresses breast cancer metastasis via inhibition of mitochondrial oxidative phosphorylation and blockade of epithelial-to-mesenchymal transition.
    Zhang J; Yan L; Wei P; Zhou R; Hua C; Xiao M; Tu Y; Gu Z; Wei T
    Eur J Pharmacol; 2021 Mar; 895():173866. PubMed ID: 33454376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer.
    Flores O; Santra S; Kaittanis C; Bassiouni R; Khaled AS; Khaled AR; Grimm J; Perez JM
    Theranostics; 2017; 7(9):2477-2494. PubMed ID: 28744329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the actin cytoskeleton: selective antitumor action via trapping PKCɛ.
    Foerster F; Braig S; Moser C; Kubisch R; Busse J; Wagner E; Schmoeckel E; Mayr D; Schmitt S; Huettel S; Zischka H; Mueller R; Vollmar AM
    Cell Death Dis; 2014 Aug; 5(8):e1398. PubMed ID: 25165884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further lead optimization on Bax activators: Design, synthesis and pharmacological evaluation of 2-fluoro-fluorene derivatives for the treatment of breast cancer.
    Liu G; Kim H; Wang P; Fricke DR; Chen H; Wang T; Shen Q; Zhou J
    Eur J Med Chem; 2021 Jul; 219():113427. PubMed ID: 33845235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex.
    Liu HJ; Jiang XX; Guo YZ; Sun FH; Kou XH; Bao Y; Zhang ZQ; Lin ZH; Ding TB; Jiang L; Lei XS; Yang YH
    Acta Pharmacol Sin; 2017 Oct; 38(10):1381-1393. PubMed ID: 28504248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells.
    Hou L; Zhao X; Wang P; Ning Q; Meng M; Liu C
    PLoS One; 2013; 8(1):e53491. PubMed ID: 23326440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyphyllin I induces mitophagic and apoptotic cell death in human breast cancer cells by increasing mitochondrial PINK1 levels.
    Li GB; Fu RQ; Shen HM; Zhou J; Hu XY; Liu YX; Li YN; Zhang HW; Liu X; Zhang YH; Huang C; Zhang R; Gao N
    Oncotarget; 2017 Feb; 8(6):10359-10374. PubMed ID: 28060722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The α-tocopherol derivative ESeroS-GS induces cell death and inhibits cell motility of breast cancer cells through the regulation of energy metabolism.
    Zhao L; Zhao X; Zhao K; Wei P; Fang Y; Zhang F; Zhang B; Ogata K; Mori A; Wei T
    Eur J Pharmacol; 2014 Dec; 745():98-107. PubMed ID: 25446928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hirsutine induces apoptosis of human breast cancer MDA-MB-231 cells through mitochondrial pathway].
    Huang QW; Zhai NN; Huang T; Li DM
    Sheng Li Xue Bao; 2018 Feb; 70(1):40-46. PubMed ID: 29492513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small size fullerenol nanoparticles suppress lung metastasis of breast cancer cell by disrupting actin dynamics.
    Qin Y; Chen K; Gu W; Dong X; Lei R; Chang Y; Bai X; Xia S; Zeng L; Zhang J; Ma S; Li J; Li S; Xing G
    J Nanobiotechnology; 2018 Jun; 16(1):54. PubMed ID: 29935539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics.
    Brandhagen BN; Tieszen CR; Ulmer TM; Tracy MS; Goyeneche AA; Telleria CM
    BMC Cancer; 2013 Jan; 13():35. PubMed ID: 23351358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
    Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
    Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas.
    Sulaiman MK; Chu Z; Blanco VM; Vallabhapurapu SD; Franco RS; Qi X
    Mol Cancer; 2015 Apr; 14():78. PubMed ID: 25889084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance.
    Wang H; Yin H; Yan F; Sun M; Du L; Peng W; Li Q; Feng Y; Zhou Y
    Oncotarget; 2015 Feb; 6(5):2827-42. PubMed ID: 25605018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
    Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
    Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Novel Anticancer Aryl-Ureido Fatty Acid CTU Increases Reactive Oxygen Species Production That Impairs Mitochondrial Fusion Mechanisms and Promotes MDA-MB-231 Cell Death.
    Tam S; Umashankar B; Rahman MK; Choucair H; Rawling T; Murray M
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39408906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.